Gastroenterology and Pharmacotherapy

The medical management of patients with gastrointestinal diseases is advancing rapidly. Specific attention was given to the future prospects for medical management of 3 common gastrointestinal disease areas: antisecretory therapy, chronic hepatitis C, and inflammatory bowel disease. Newer strategies to eradicate hepatitis C virus infection using different interferons, such as interferon alfacon-1 or higher doses of peginterferon, or long-term maintenance peginterferon, are undergoing study and show promise based on data from preliminary studies. Several immunomodulators have promise in inflammatory bowel disease, although the risk-benefit ratio and costs of therapy require evaluation. Nevertheless, the success of new biologics such as anti-TNFα agents augurs well for effective future therapies.

    Related Conference of Gastroenterology and Pharmacotherapy

    September 11-12, 2017

    12th Euro-Global Gastroenterology Conference

    Paris, France
    September 13-14, 2017
    10 Plenary Forums - 1Event

    2nd International Conference on Pancreatic Disorders and Treatment
    (10 Plenary Forums - 1Event)

    Dallas, Texas, USA
    October 16-18, 2017

    2nd World Summit on Metabolic Disorders

    Chicago, Illinois, USA
    December 07-08, 2017

    2nd International Conference on Digestive Diseases

    Madrid, Spain
    December 14-15, 2017

    11th World Gastroenterologists Summit

    Dubai, UAE
    March 19-20, 2018

    12th Global
    Gastroenterologists Meeting

    Barcelona, Spain
    April 09-11, 2018

    12th International Conference on Abdominal Imaging and Endoscopy

    Amsterdam, Netherlands
    April 09-11, 2018

    6th World Congress on Hepatitis & Liver Diseases

    Amsterdam, Netherlands
    May 28-29, 2018

    6th International Conference on Hepatology

    Osaka, Japan

    Gastroenterology and Pharmacotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in